Insights

Intensive use of nebulized beta2-agonists for severe pediatric asthma may cause lactic acidosis. Symptoms improved after reducing or stopping the medication, suggesting a direct link.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Respiratory Medicine
  • Clinical Biochemistry

Background:

  • Acute severe asthma in children requires intensive treatment.
  • Nebulized beta2-agonists are a cornerstone therapy for acute severe asthma.
  • Potential adverse effects of high-dose beta2-agonist therapy require ongoing investigation.

Observation:

  • Four pediatric patients with acute severe asthma developed lactic acidosis during intensive nebulized beta2-agonist treatment.
  • Peak lactic acidosis concentrations ranged from 5.2 to 13 mmol/l.
  • Lactic acidosis resolved within 24 hours after discontinuing or decreasing beta2-agonist dosage.

Findings:

  • Intensive nebulized beta2-agonist therapy is a potential cause of lactic acidosis in pediatric patients with severe asthma.
  • The severity of lactic acidosis correlated with beta2-agonist dosage.
  • Discontinuation or dose reduction of beta2-agonists led to rapid improvement of lactic acidosis.

Implications:

  • Clinicians should consider lactic acidosis as a potential complication of intensive beta2-agonist therapy in pediatric severe asthma.
  • Monitoring lactate levels may be warranted in pediatric patients receiving high-dose beta2-agonists.
  • Further research is needed to elucidate the mechanism and confirm the association between beta2-agonists and lactic acidosis in this population.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...